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Abstract
Poor social functioning is a hallmark of schizophrenia. The purpose of this study was to examine
social functioning in individuals at clinical high risk for psychosis. Social functioning was assessed
in a sample of 86 clinical high risk (CHR) individuals and compared to that of 50 first-episode of
psychosis (FE) subjects, 53 multi-episode schizophrenia subjects (ME) and 55 non-psychiatric
controls (NPC). Subjects were assessed on the Social Functioning Scale (SFS), the Role Functioning
subscale of the Quality of Life Scale (QLS-role), and the premorbid functioning scale. On the SFS,
the CHR group did not differ significantly from the FE and ME groups and all were impaired relative
to the NPCs. On QLS-role, the CHR group performed significantly better than the ME patients and
significantly worse than NPCs. CHR subjects did not differ from patients in terms of premorbid
functioning. This study demonstrates that even at the pre-psychotic phase of the illness, these young
people are demonstrating significant deficits in social functioning, supporting that social deficits are
present long before the onset of psychotic symptoms.
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1. Introduction
Poor social functioning is a hallmark of schizophrenia (Couture et al., 2006). For many
individuals, in fact, it possibly is even more debilitating than and certainly more stable than
the positive symptoms that mark the onset of the illness. Furthermore, there are suggestions
that deficits in social functioning are present long before the onset of the first psychotic episode
and such deficits are often prognostic of later social functioning (Addington & Addington,
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2005; Hafner et al., 1999; Davidson et al., 1999). However, some of these studies are
retrospective (e.g. Hafner et al.) with a focus on functioning in the period before the onset of
the illness and other studies are prospective (e.g., the high risk studies or epidemiological
studies) examining social functioning in the pre-adolescent period well before the onset of full
psychosis (Cannon et al., 1999; Cannon et al., 2002; Jones et al., 1994; Schiffman et al.,
2004b; Schiffman et al., 2004a).
There are few prospective studies examining those who are at clinical high risk (CHR) of
developing psychosis, i.e. individuals in the putatively prodromal phase of the illness. An
association between low or deteriorated functioning and onset of psychosis has been reported
(Mason et al., 2004; Yung et al., 2004; Yung et al., 2003). For example, Yung and colleagues
reported that a Global Assessment of Functioning Score (GAF) score of 50 or below at baseline
was associated with psychosis at 12 month follow-up (Yung et al., 2003). In a small sample,
Penn and colleagues demonstrated that CHR subjects had significantly impaired social skills
relative to normal controls and did not differ from those in the early stages of a psychotic illness
(Penn et al., 2007). A recent study that examined subjective experience of functioning
(particularly in school and work settings) demonstrated that young CHR individuals were
similar to first episode adolescents and impaired relative to normal controls (Ballon et al.,
2007).
Thus, it would be important to determine the level of social functioning in a large sample of
individuals who are seen to be at clinical high risk of psychosis using measures that are well
established and specifically designed for measuring social functioning in schizophrenia. The
aim of this paper is to compare both premorbid and social functioning in a large sample of
CHR subjects with the functioning of non-psychiatric controls, first-episode psychosis patients
and multi-episode schizophrenia patients.
2. Method
2.1 Subjects
The sample consisted of 86 clinical high risk individuals (CHR), 50 individuals with a first
episode of psychosis (FE), 53 subjects with a chronic course of schizophrenia (ME) and 55
non-psychiatric controls (NPC). All CHR subjects are participants in the PREDICT study at
the University of Toronto (n = 34), the University of North Carolina at Chapel Hill (UNC) (n
= 32) and Yale University (n = 20), a three site study determining predictors of conversion to
psychosis. All CHR subjects met the Criteria of Prodromal States (COPS) as evaluated using
the Structured Interview for Prodromal Syndromes (SIPS) (Miller et al., 2003). The COPS
includes 3 criteria: attenuated positive symptom state (APS), brief intermittent positive
symptoms (BIPS) and genetic risk and deterioration (GRD). The APS and BPS criteria are
based on duration and severity of prodromal symptoms and the GRD requires either a first
degree relative with a psychotic disorder or the subject having schizotypal personality disorder
(SPD) plus at least a 30% drop in functioning on the General Assessment of Functioning (GAF)
scale in the past 12 months. Because social functioning is part of the GRD criteria we only
included subjects who met Attenuated Positive Symptom State Criteria, which included the
emergence or worsening over the past year of a non-psychotic disturbance of thought content,
thought process or perceptual abnormality. None of the CHR subjects met any DSM IV criteria
for any psychotic disorders.
The FE, ME and NPC subjects were specifically recruited for studies examining social
functioning in psychosis at the University of Calgary and have been well described elsewhere
(Addington et al., 2005; Addington et al., 2006a; Addington et al., 2006b). Using the SCID,
all of the FE and ME subjects met DSM-IV criteria for a schizophrenia spectrum disorder
(schizophrenia, schizoaffective disorder, schizophreniform) except nine FE subjects who met
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criteria for other psychotic disorders (delusional disorder, brief psychotic disorder, psychosis
NOS). Based on SCID criteria there were no current or past psychiatric disorders in the NPCs.
Demographics are presented in Table 1.
2.2 Measures
Social functioning was assessed using the Social Functioning Scale (SFS), a self-report
questionnaire developed for outpatients with schizophrenia that has excellent psychometric
properties (Birchwood et al., 1990). The SFS has a total score and 7 sub-scores: Withdrawal/
social engagement, Interpersonal communication, Independence-performance, Independence-
competence, Recreation, Prosocial, and Employment/Occupation. To better assess role
functioning, we also used the instrumental role functioning subscale of the Quality of Life
Scale (QLS) (Heinrichs et al., 1984). Premorbid Functioning was assessed with the Premorbid
Adjustment Scale (PAS) (Cannon-Spoor et al., 1982). The PAS measures premorbid
functioning in four areas of development: (i) sociability/withdrawal (ii) peer relationships (iii)
ability to function outside the nuclear family and (iv) capacity to form intimate socio-sexual
ties, at each of four developmental stages, namely, childhood (up to age 11), early adolescence
(12–15 years), late adolescence (16–18 years), and adulthood (19 and up) (van Mastrigt &
Addington, 2002). Overall scores on the PAS are an average of the developmental periods that
are rated. Information for all three measures of social functioning was obtained from the
subject.
2.3 Procedures
Formal consent was obtained from all subjects. In the PREDICT study, all three sites
participated in a rater training program developed at Yale University that teaches clinical
researchers to identify features of the prodromal syndrome with good reliability (Miller et al.,
2003). The kappa statistic was used to compare trainee agreement with the “gold standard”
diagnosis of presence or absence of a prodromal syndrome. Kappa was greater than 0.80 at all
sites and the overall kappa was 0.90. All sites participated in weekly conference calls chaired
by JA to review criteria for every CHR case admitted to the study. Raters were trained on the
SCID at each site by the respective PIs. However, the thorough review of all attenuated
symptoms on the consensus calls ruled out the presence of any symptoms at a psychotic level.
The DSM-IV diagnoses for the Calgary subjects were made using the SCID-I by JA and DA.
Interrater reliability was determined by 100% agreement on the diagnosis and at least 80%
agreement for symptom presence. Other detailed descriptions of quality training and good to
excellent reliability for the data from the control subjects have been described elsewhere
(Addington et al., 2006a).
2.4 Statistical Analysis
One-way ANOVAs were used to compare the four groups on demographics. Pearson
correlations were used to assess the relationship of the two scales to one another. One-way
between groups MANOVA was used to compare groups on the two measures of functioning
controlling for age. One-way ANOVAS were used to compare groups on social functioning
measures, including subscales. On all ANOVAs, Tukey post-hoc tests were used to determine
specific group differences.
Results
One-way ANOVAS demonstrated that there were significant differences amongst all groups
on age except between the CHR and NPC group. These results are presented in Table 1.
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The SFS and the QLS-role were significantly associated (r = 0.43, p < 0.0001) in the total
sample; not significantly associated in the NPCs and MEs and significantly associated in the
FEs (r = 0.49, p < 0.001) and in the CHRs (r = 0.42, p < 0.001). This result is not surprising as
the two measures are measuring different aspects of social functioning. However, the QLS-
role was significantly associated in each group with the employment sub score of the SFS (r
ranged from 0.66–.0.72, p < 0.001).
A one-way between-groups MANOVA was performed to determine group differences on the
two measures of social functioning controlling for age. There was a statistically significant
difference between groups on the combined dependent variables: F(4, 240) = 30.12; p = 0.0001;
Wilks’ Lambda = 0.64; partial eta squared = 0.20. Both the SFS: F(2, 242) = 42.86; p = 0.0001;
partial eta squared = 0.26 and the QLS-role: F(2, 242) = 33.89; p = 0.001; partial eta squared
= 0.22 were statistically significant. The one-way ANOVA (See Table 2) demonstrates that on
the SFS and the QLS-role, the NPCs performed significantly better than the three other groups.
On the SFS overall and most of the sub scores there were no significant differences between
the CHR, FE and ME groups. There were variations on ratings on four of the sub scores,
Employment, Independence-competence, Independence-performance and Prosocial. On
Employment, although the CHR group had significantly lower ratings than the NPC group,
they were significantly better than the patient groups. On Independence-performance, the ME
and NPC performed significantly better than the FE and CHR with all of the groups scoring
in a range that is not indicative of problems. On Independence–competence, the CHR had the
highest ratings followed by the NPC with no significant difference between ME and FE groups.
On Prosocial, the CHR group was significantly better than the other three groups. On the QLS-
role, the CHR group performed similar to the FE group, significantly poorer than the NPC and
significantly better than the MEs. These results are presented in Table 2.
On the Premorbid Functioning Scale (PAS), there were no significant differences between the
CHR group and the patient groups on the scores for childhood, early adolescence and late
adolescence and overall premorbid functioning. However, on the adult scale, the CHR subjects
performed significantly better. It should be noted that 44% of the CHR group and 24% of the
FE group were under 19 and did not have adult premorbid ratings. This however, is not reflected
in the overall score, which is based only on developmental periods that have been reached. See
Table 2.
Discussion
This study is one of the first to examine social functioning in a group of individuals at high
risk of developing psychosis in comparison to non-psychiatric controls, first-episode psychosis
subjects and patients with a more established schizophrenia illness. Results of this study
confirm that these young CHR individuals have clear deficits in social and premorbid
functioning equivalent to individuals with FE and ME psychosis and schizophrenia. Results
also demonstrate equivalent patterns of premorbid functioning. The poorer adult ratings of the
ME and FE subjects possibly reflect current functioning and that less of the CHR subjects
reached this developmental period.
Overall ratings of social functioning suggest that the CHR groups are performing at an
equivalent level to the patient groups. For role functioning and employment, although the CHR
group are on average not functioning as well as non-psychiatric peers, they are not yet at an
equivalent level to patients. In examining the subscales of social functioning, we can speculate
that we are already seeing the withdrawal and poorer interpersonal communication typical of
patients with psychosis as it is on these two subscales that the CHR subjects do not differ
significantly from the patient groups. There is some variation on the other subscales that tend
to reflect recreational and independent living skills in which individuals may engage. This
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suggests some impairment in the CHR group’s performance and competence in independent
living and in the ability to begin social interactions relative to non-psychiatric peers. Perhaps
the onset of the prodromal symptoms is beginning for some to have an impact at this early
stage on coping with daily living. This may in fact encourage help seeking.
This study is limited in that it is cross-sectional and does not address predictors of conversion.
Secondly, the “control” subjects are from a different site. However, the social functioning
ratings of the control samples are consistent with the ratings reported in the literature from
other research centers using these measures in both FE and ME groups (Dickerson et al.,
1991;1995; Pinkham et al., 2007). Thirdly, this is the first time to our knowledge that the SFS
has been used with a clinical high risk sample and possible needs further validation. The
strengths of this study are the reasonably large numbers in each group, the well-defined clinical
high risk group and the use of three control groups.
These CHR subjects are help-seeking and have significant disability, thus highlighting the
importance of characterizing non-psychotic outcomes of the putatively prodromal period.
Although these social deficits are not specific enough indicators of schizophrenia to support
pharmacological intervention, there is a wide range of psychosocial interventions, which are
relatively inexpensive, low risk and may offer some benefits for individuals at risk of psychosis.
Although it is highly likely that less than 50% of this CHR sample will go on to develop a full
blown psychotic illness, the attenuated positive symptoms are accompanied by levels of
premorbid and current social functioning that is similar to that observed in individuals with
schizophrenia. Thus, this suggests that this is a clinical sample that requires help in its own
right. For those who do convert, psychosocial intervention at this early stage could potentially
improve the course and outcome of the illness and for those who do not convert, intervention
is much needed to improve the quality of their lives and reduce distress.
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